Symptoms and General Pathology

All Conditions

Neoplasms

Digestive System Diseases

Pain

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Colonic Diseases

Intestinal Diseases

Rectal Diseases

4 behavioral cancer pain intervention sessions delivered by mobile application. Patient-focused intervention. PainPac uses Social Cognitive Theory to promote behaviors to improve pain, self-efficacy for pain management, and pain-related quality of life indices. It also uses real-time data to personalize the intervention and messaging to participants. The app also has interactive components to improve coping skills engagement.

4 behavioral cancer pain intervention sessions delivered by videoconferencing by a pain therapist in the medical center to the patient in their natural environment (e.g., home). Sessions will be scheduled weekly for 45-60 min and mimic in person sessions. PCST-Video session content is matches the PainPac skills modules. PCST-Video participants will complete assessments at the same intervals as PainPac participants.

Patient-focused behavioral pain intervention delivered via mobile application.

PainPac

Sarah A Kelleher, PhD

PainPac is innovative in its potential to integrate with healthcare systems through electronic medical records (EMRs). PainPac leverages technology to increase patient access to interventions and uses real-time assessment to improve care. PainPac is positioned to rapidly provide improved care through combining biological data (e.g., EMRs, patient collected) with behavioral data to dramatically improve outcomes. PainPac could track beneficial outcomes related to clinical pain scores (e.g., patients with scores 4-8 benefit) and intervention implementation could be based on this; a more advanced possibility is use of geospatial tracking to predict space/time where pain is likely to impact functioning and push an intervention strategy - behavioral or pharmacological. PainPac is designed for future transmission of data to EMRs to inform providers of patient status. This work will provide data to bypass traditional efficacy trials and move quickly to a large effectiveness trial.

The investigators will use a pilot RCT to examine PainPac feasibility, patient burden, engagement, acceptability, and initial pain-related outcomes, compared to a therapist led videoconference delivered behavioral pain intervention (PCST-Video) in colorectal cancer patients with pain. Investigators will use quantitative and qualitative data to optimize PainPac. Participants will complete assessments at pre-treatment (A1), post-treatment (A2; 4 weeks post-A1), and 1 month follow-up (A3; 1 month post-A2) (months 5-22). The pain management strategies are relevant and efficacious across cancer types. Due to the pilot nature of this work, investigators will enroll an opportunity sample of colorectal cancer patients.

PainPac is a patient-focused intervention developed using cognitive-behavioral theory and empirically supported strategies to enhance patients' ability to manage their pain. PainPac is a mobile app available to participants on a smartphone or tablet. PainPac uses Social Cognitive Theory to promote behaviors to improve pain, self-efficacy for pain management, and pain-related quality of life indices. It also uses real-time data to personalize the intervention and messaging to participants. PainPac contains 4 modules, each including a skill that has shown efficacy for reducing pain in patients with cancer. Patients are prompted to complete one module each week for 4 weeks. The app also has interactive components to improve coping skills engagement.

Participants randomized to PCST-Video will receive 4 behavioral cancer pain intervention sessions delivered by videoconferencing by a pain therapist in the medical center to the patient in their natural environment (e.g., home). Sessions will be scheduled weekly for 45-60 min and mimic in person sessions. PCST-Video session content is matches the PainPac skills modules described above. PCST-Video participants will complete assessments at the same intervals as PainPac participants.

Aim 1: Test whether PainPac is feasible (primary aim), low burden, engaging, and acceptable.

Aim 2: Examine the impact of PainPac on pain severity, pain interference, pain self-efficacy, and quality of life.

Aim 3: Gather quantitative and qualitative post-treatment data on patients' preferences, barriers, and facilitators regarding PainPac to update and optimize PainPac for a future large randomized clinical effectiveness trial.

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings

Reaching target accrual (N=60) within 15 months.

\<25% attrition by 1-month post-baseline.

Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the study baseline assessment.

Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the post-study sessions assessment.

Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the 1-month follow up assessment.

Includes protocol adherence indicated by calculating the degree to which participants are willing/able to complete the 4 PainPac skills modules or 4 PCST-Video sessions.

10-item Client Satisfaction Questionnaire (CSQ). This questionnaire contains 10 items rated from 1=low acceptability to 4=high acceptability; scores are created by utilizing the Likert Scale to average Client Satisfaction Questionnaire answers resulting in a score range from 1-4. The participant will complete this acceptability questionnaire as part of the post-session follow up assessment.

Atkinson's tool will also be used to assess perceived attributes of mHealth innovations. Tool has 30 items about mHealth, participant indicates their level of agreement or disagreement on a 6-point Likert scale: l=strongly agree, 2=agree, 3=somewhat agree, 4=somewhat disagree. 5=disagree, and 6=strongly disagree.

Post-intervention, measured together as one measure, patients will be asked 10 items modeled from labs previous work. Items will be answered on a 0-10 scale with 0=low preference, barrier, belief and 10=high preference, barrier, belief.

Post-Intervention, 10 items on a 10 point scale from 0=not at all confident to 10=completely confident. Patients are asked 10 items regarding their confidence in ability to use technology (computer and smartphone app).

Pain will be assessed with the Brief Pain Inventory (BPI). Patients will rate their "worst", "least", "average", and "now" pain from 0=no pain to 10=worst pain imaginable. An average of the responses to these items is used to create a single pain severity score.

Pain interference will be assessed with the Brief Pain Inventory (BPI) - Pain Interference Scale. Patients will rate how much pain interfered with a variety of activities and mood states over the last 7 days from 0=does not interfere to 10=completely interferes. An average of the responses to these items is used to create a single pain severity score.

5-item self-efficacy subscale of the Chronic Pain Self-Efficacy Scale. Items ask about patients' certainty about pain control, pain during activities, and reducing pain without extra medication using a 10=very uncertain to 100=very certain scale and averaged. The 10-item Computer Self-Efficacy Scale will be used to ask about patients' confidence in using technology to receive a behavioral pain intervention.

12-item measure developed in the lab through a NCI study examining burdens with accessing care after a cancer diagnosis. Patients will rate difficulty completing the intervention (PainPac modules or PCST-Video sessions) on a 1=not at all to 5=very much scale based on physical, emotional, financial burdens. A summated scale will be used to assess internal validity using Cronbach's alpha of 0.75.

Engagement is defined as the number of times/week participants log into PainPac and practice the skills. Engagement will be assessed based on app data and patient self-report. Patient Engagement will be assessed by electronic app data (e.g., PainPac weekly log-ins) and patient self-report defined as the number of times per week they practice the coping skills. \>3 times/week will serve as the benchmark; if participants log into PainPac and/or practice the coping skills \<3 times/week, PainPac will not be considered engaging.

Centers for Disease Control Health Related Quality of Life 14-item measure. This measure assesses healthy days in the last month and activity limitations and symptoms.

Post-intervention and 1-month follow up, 8 items on a 5 point scale from 1=never, 2=rarely, 3=sometimes, 4=often, 5=always. Patients are asked 8-items regarding "in the past 7 days I felt..." to assess their emotional distress levels.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)	NCT05686122	Colorectal Canc...	PainPac	18 Years -	Duke University
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)	NCT05686122	Colorectal Canc...	PainPac	18 Years -	Duke University
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)	NCT05686122	Colorectal Canc...	PainPac	18 Years -	Duke University

Spots Global Cancer Trial Database for painpac

Every month we try and update this database with for painpac cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for painpac

Every month we try and update this database with for painpac cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for painpac cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.